<DOC>
	<DOCNO>NCT00695201</DOCNO>
	<brief_summary>The purpose study see well patient tolerate side effect treatment Floxuridine , Oxaliplatin Irinotecan . We also want know method use together useful way treat cancer . We study drug know best dos use alone . We yet know well drug work . This study tell u best dos drug give period time .</brief_summary>
	<brief_title>Hepatic Arterial Infusion With Floxuridine Dexamethasone Combination With Intravenous Oxaliplatin Plus Irinotecan Patients With Unresectable Hepatic Metastases From Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>History histologically confirm colorectal adenocarcinoma metastatic liver clinical radiographic evidence extrahepatic disease . Confirmation diagnosis must perform MSKCC . Patient 's liver metastases must deem unresectable comprise &lt; 70 % liver parenchyma . A patient may prior chemotherapy previously untreated . Patient may receive prior treatment FUDR &gt; 2 dos Oxaliplatin . KPS &gt; = 60 % . WBC &gt; = 3,000 cells/mm3 platelet count &gt; = 100,000 cells/mm3 within 14 day registration . Creatinine &lt; = 1.5 mg/dl within 14 day registration . Total serum bilirubin &lt; = 2.0 mg/dl within 14 day registration . No active concurrent malignancy : except patient 's potentially resectable colorectal primary . Patient must obstruction GI GU tract . Patient must current , symptomatic peripheral sensory neuropathy . No prior radiation liver . No active infection , ascites , hepatic encephalopathy . Age â‰¥ 18 year . Female patient pregnant lactate . Signed informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>DEXAMETHASONE</keyword>
	<keyword>FLOXURIDINE</keyword>
	<keyword>IRINOTECAN ( CPT-11 ) CAMPTOSAR</keyword>
	<keyword>OXALIPLATIN</keyword>
</DOC>